ProFound AI
Discover the ProFound impact of artificial intelligence for digital breast tomosynthesis
Now available in the United States
Discover the Xoft Electronic Brachytherapy (eBx) System
Explore Breakthrough Technology Delivering Excellent Results
<
>
Who is iCAD?
iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. We work passionately to provide precise, powerful healthcare solutions expertly engineered to optimize operational efficiency, clinician confidence and patient outcomes.
Recent News
December 27, 2018
iCAD Announces CFO Transition
December 20, 2018
iCAD, Inc. Announces $7.0 Million Private Placement of Unsecured Subordinated Convertible Debentures
December 7, 2018
iCAD Announces FDA Clearance of ProFound AI™ for Digital Breast Tomosynthesis
November 26, 2018
iCAD Unveils ProFound AI™ for Digital Breast Tomosynthesis at RSNA 2018
» View All News »
CONNECT
© 2018, iCAD Inc. All rights reserved. iCAD, the iCAD logo,, PowerLook, ProFound AI, ProFound, Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are trademarks of iCAD, Inc. Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.
<
>
ProFound AI
Discover the ProFound impact of artificial intelligence for digital breast tomosynthesis
Now available in the United States
Discover the Xoft Electronic Brachytherapy (eBx) System
Explore Breakthrough Technology Delivering Excellent Results